Ivermectin Controversy & Retracted Studies

Posted: October 8, 2021 in -
Tags: , , , , ,

Merck, the manufacturer, put out a statement saying there is no evidence of efficacy for ivermetin in fighting Covid. They do stand to make money if it sells, but they also will make much more money from their other new treatment, molnupiravir.

Merck Statement on Ivermectin use During the COVID-19 Pandemic
  • No scientific basis for a potential therapeutic effect against COVID-19 from pre-clinical studies; 
  • No meaningful evidence for clinical activity or clinical efficacy in patients with COVID-19 disease, and; 
  • A concerning lack of safety data in the majority of studies.

Questionable studies have been pulled.

Your Comment

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s